Hopp til innhold

Valgte elementer er lagt i handlekurven

Gå til handlekurv
Artikkel

Publikasjonsliste for Meldingssystem for smittsomme sykdommer (MSIS)

Oversikt over forskningsartikler der data fra Meldingssystem for smittsomme sykdommer (MSIS) er brukt.

Colourbox.com
Colourbox.com

Hopp til innhold

Forskere og andre kan be om tilgang til statistikk eller data fra Meldingssystem for smittsomme sykdommer (MSIS) og de andre helseregistrene som Folkehelseinstituttet er databehandlingsansvarlig for. Helseregistre er en unik kilde til kunnskap om befolkningens helse, årsaker til sykdom og kvaliteten på helse- og omsorgstjenestene.

Dette er en oversikt over artikler fra forskning hvor helseregistre er brukt som datakilde, publisert i vitenskapelige tidsskrift. Listene er basert på metodiske søk i internasjonale artikkeldatabaser. De vil kunne være ufullstendige, avhengig av hvordan kildeopplysningene er angitt i artiklene.

For å søke om tilgang til statistikk, data eller biologisk materiale fra helseregistre eller helseundersøkelser som Folkehelseinstituttet forvalter, må du benytte elektronisk søknadsskjema.

2017

Andreassen AES, Jacobsen CM, de Blasio B, White R, Kristiansen IS, Elstrom P. The impact of methicillin-resistant S. aureus on length of stay, readmissions and costs: a register based case-control study of patients hospitalized in Norway. Antimicrob 2017;6:74

Blomfeldt A, Larssen KW, Moghen A, Gabrielsen C, Elstrom P, Aamot HV, et al. Emerging multidrug-resistant Bengal Bay clone ST772-MRSA-V in Norway: molecular epidemiology 2004-2014. European Journal of Clinical Microbiology and Infectious Diseases 2017;36(10):1911-21.

Egenberg HEI, Henriette; Karlsrud, Anniken; Weisser, Kristin Howlid; Ødegård, Marianne Meier; Majeed, Heidi Vego. Pneumokokkvaksinasjon av eldre på sykehjem. Et kvalitetsforbedringsprosjekt ved Modumheimen Sykehjem [Master thesis]: Universitet i Oslo; 2017.

Francesco Di R, Bjørnholt JV, Leegaard TM, Fossum Moen AE, Birgitte Freiesleben de B. MRSA infections in Norway: A study of the temporal evolution, 2006-2015. PLoS One 2017;12(6).

Haukaas FS, Arnesen TM, Winje BA, Aas E. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis. The European Journal of Health Economics : HEPAC 2017;18(4):405-15.

Lill T, Bakken IJ, Gunnes N, Ghaderi S, Stoltenberg C, Magnus P, et al. Narcolepsy and hypersomnia in Norwegian children and young adults following the influenza A(H1N1) 2009 pandemic. Vaccine 2017;35(15):1879-85.

Meijerink H, White RA, Lovlie A, Birgitte Freiesleben de B, Dalgard O, Amundsen EJ, et al. Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973-2030. BMC Infect Dis 2017;17.

Mysterud A, Jore S, Østerås O, Viljugrein H. Emergence of tick-borne diseases at northern latitudes in Europe: a comparative approach. Scientific Reports (Nature Publisher Group) 2017;7:1-12.

PÄRn T, Dahl V, Lienemann T, Perevoscikovs J, De Jong B. Multi-country outbreak of Salmonella enteritidis infection linked to the international ice hockey tournament. Epidemiology and Infection 2017;145(11):2221-30.

Samuelsen Ø, Overballe-Petersen S, Bjørnholt JV, Brisse S, Doumith M, Woodford N, et al. Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway, 2007 to 2014. PLoS One 2017;12(11).

Årdal C, Blix HS, Plahtea J, Røttingen J-A. An antibiotic's journey from marketing authorization to use, Norway/Parcours d'un antibiotique, de son autorisation de mise sur le marché à son utilisation, en Norvège/El recorrido de un antibiótico desde la autorización de comercialización a su uso en Noruega. World Health Organization Bulletin of the World Health Organization 2017;95(3):220-6.

2016

Abitbol, C. L., & Moxey-Mims, M. (2016). Chronic kidney disease: Low birth weight and the global burden of kidney disease. Nature Reviews Nephrology, 12(4), 199-200. doi:https://dx.doi.org/10.1038/nrneph.2016.19

Bourgeois, A. C., Zulz, T., Soborg, B., Koch, A., & International Circumpolar Surveillance--Tuberculosis Working, G. (2016). Descriptive review of tuberculosis surveillance systems across the circumpolar regions. International Journal of Circumpolar Health, 75, 30322. doi:https://dx.doi.org/10.3402/ijch.v75.30322

Guzman-Herrador, B., de Blasio, B. F., Lund, V., MacDonald, E., Vold, L., Wahl, E., & Nygard, K. (2016). [Waterborne outbreaks in Norway 2003-2012]. Tidsskrift for den Norske Laegeforening, 136(7), 612-616. doi:https://dx.doi.org/10.4045/tidsskr.15.0114

MacDonald, E., Einoder-Moreno, M., Borgen, K., Brandal, L. T., Diab, L., Fossli, O., . . . Nygard, K. (2016). National outbreak of Yersinia enterocolitica infections in military and civilian populations associated with consumption of mixed salad, Norway, 2014. Eurosurveillance, 21(34), 11-19. doi:10.2807/1560-7917.es.2016.21.34.30321

MacDonald, E., Vestrheim, D. F., White, R. A., Konsmo, K., Lange, H., Aase, A., . . . Vold, L. (2016). Are the current notification criteria for Lyme borreliosis in Norway suitable? Results of an evaluation of Lyme borreliosis surveillance in Norway, 1995-2013. BMC Public Health, 16, 729. doi:https://dx.doi.org/10.1186/s12889-016-3346-9

Midgard, H., Bramness, J. G., Skurtveit, S., Haukeland, J. W., & Dalgard, O. (2016). Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study. PloS One, 11(11), e0166451. doi:https://dx.doi.org/10.1371/journal.pone.0166451

Nguipdop-Djomo, P., Heldal, E., Rodrigues, L. C., Abubakar, I., & Mangtani, P. (2016). Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study. The Lancet Infectious Diseases, 16(2), 219-226. doi:https://dx.doi.org/10.1016/S1473-3099(15)00400-4

2015

Arnesen, T. M., Seterelv, S., Norheim, G., Helgebostad, S. R., Mannsaker, T., Ly, I. N., . . . Steen, T. W. (2015). Tuberculosis outbreak in Eastern Norway. Tidsskrift for den Norske Laegeforening, 135(23-24), 2160-2164.

Guzman Herrador, B. R., Ronning, K., Borgen, K., Mannsaker, T., & Dahle, U. R. (2015). Description of the largest cluster of tuberculosis notified in Norway 1997-2011: is the Norwegian tuberculosis control programme serving its purpose for high risk groups? BMC Public Health, 15, 367.

Klovstad, H., & Aavitsland, P. (2015). Denominators count: supplementing surveillance data for genital Chlamydia trachomatis infection with testing data, Norway, 2007 to 2013. Eurosurveillance, 20(36), 20-27.

MacDonald, E., White, R., Mexia, R., Bruun, T., Kapperud, G., Lange, H., . . . Vold, L. (2015). Risk Factors for Sporadic Domestically Acquired Campylobacter Infections in Norway 2010-2011: A National Prospective Case-Control Study. PLoS ONE [Electronic Resource], 10(10), e0139636.

Magnus, P., Gunnes, N., Tveito, K., Bakken, I. J., Ghaderi, S., Stoltenberg, C., . . . Haberg, S. E. (2015). Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. Vaccine, 33(46), 6173-6177.

Munson, S., Raluy-Callado, M., Lambrelli, D., Wasiak, R., Eriksson, D., & Gray, S. (2015). Clinical burden of pneumonia, meningitis and septicemia in Norway 2 years after 7-valent pneumococcal conjugate vaccine introduction. Scandinavian Journal of Public Health, 43(6), 657-666.

2014

Haugum, K., Brandal, L. T., Lindstedt, B. A., Wester, A. L., Bergh, K., & Afset, J. E. (2014). PCR-based detection and molecular characterization of shiga toxin-producing Escherichia coli strains in a routine microbiology laboratory over 16 years. Journal of Clinical Microbiology, 52(9), 3156-3163.

Jakopanec, I., Grjibovski, A. M., Nilsen, O., Blystad, H., & Aavitsland, P. (2013). Trends in HIV infection surveillance data among men who have sex with men in Norway, 1995-2011. BMC public health, 13, 144.

Jenssen, G. R., Hovland, E., Bjerre, A., Bangstad, H. J., Nygard, K., & Vold, L. (2014). Incidence and etiology of hemolytic-uremic syndrome in children in Norway, 1999-2008-a retrospective study of hospital records to assess the sensitivity of surveillance. BMC Infectious Diseases, 14, 9.

Larssen, K. W., Bergh, K., Heier, B. T., Vold, L., & Afset, J. E. (2014). All-time high tularaemia incidence in Norway in 2011: report from the national surveillance. European Journal of Clinical Microbiology & Infectious Diseases, 33(11), 1919-1926.

Riviere, J., Carabin, K., Le Strat, Y., Hendrikx, P., & Dufour, B. (2014). Bovine tuberculosis surveillance in cattle and free-ranging wildlife in EU Member States in 2013: A survey-based review. Veterinary Microbiology, 173(3-4), 323-331.

Riviere, J., Strat, Y. l., Hendrikx, P., & Dufour, B. (2014). Bovine tuberculosis surveillance in cattle and free-ranging wildlife in European Union Member States in 2013: a survey-based review. Epidemiologie et Sante Animale, 66, 117-132.

2013

Sagbakken, M., Frich, J. C., Bjune, G. A., & Porter, J. D. (2013). Ethical aspects of directly observed treatment for tuberculosis: A cross-cultural comparison. BMC Medical Ethics, 14, 25.

Status of infectious diseases in Europe. Report of the European centre for disease prevention and control (ECDC). (2013). Boletin Epidemiologico Semanal, 21(2), 14-15.